tacalcitol Report issue

Small molecule Experimental
AACT ChEMBL Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Tacalcitol (1,24-dihydroxyvitamin D3) is a synthetic vitamin D3 analog. Tacalcitol is marketed under several names, including Curatoderm and Bonalfa.   Wikipedia

Chemistry

  • SMILES: C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CC[C@@H](O)C(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O
  • InChIKey: BJYLYJCXYAMOFT-RSFVBTMBSA-N
  • Mol. Mass: 416.65
  • ALogP: 5.56
  • ChEMBL Molecule:
    tacalcitol  
More Chemistry

Pharmacology

Alternative names

1,24-dihydroxycholecalciferol | 1,24-dihydroxyvitamin d3 | 1 alpha,24-dihydroxycholecalciferol | 1 alpha,24-dihydroxyvitamin d3 | 1 alpha,24-dihydroxyvitamin d3, (1alpha,3beta,5z,7e,24r)-isomer | 1 alpha,24-dihydroxyvitamin d3, (1alpha,3beta,5z,7e,24s)-isomer | (1 alpha,3 beta,5z,7e)-9,10-secocholesta-5,7,10(19)-triene-1,3,24-triol | curatoderm | pri-2191 | tacalcitol

Organizations (3)

Research & Development (3)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (1)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (1)


 

Psoriasis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial Organizations: 3

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue